-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

301.O1.6 301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: Thrombosis and the Endothelium

Symposia: Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, clinical trials, Bleeding and Clotting, bleeding disorders, Biological therapies, adult, artificial intelligence (AI), Antibody Therapy, Translational Research, assays, Clinical Research, platelet disorders, bioinformatics, thromboembolism, drug development, Diseases, thrombocytopenias, Immune Disorders, SARS-CoV-2/COVID-19, thrombotic disorders, Therapies, Immunotherapy, computational biology, Biological Processes, emerging technologies, Technology and Procedures, molecular biology, Study Population, Human, pathogenesis, Animal model, imaging, machine learning, omics technologies
Monday, December 12, 2022: 10:30 AM-12:00 PM
293-294 (Ernest N. Morial Convention Center)
Moderators:
Kandace Gollomp, MD, Children's Hospital of Philadelphia and Marie Alice Hollenhorst, MD, PhD, Stanford University
Disclosures:
Hollenhorst: Dova: Consultancy; Sonder Capital: Consultancy; Janssen: Consultancy.
10:30 AM

Alec A Schmaier, MD, PhD1,2, Papa Freduah Anderson, BA3*, Siyu M Chen, MS3*, Emale Darzi, MS2*, Kelsey Sack, MD, PhD4*, Criss Hartzell, PhD5*, Robert Flaumenhaft, MD, PhD6,7, Samir Parikh, MD8,9* and Sol Schulman, MD, PhD2,7

1Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
2Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
3Cardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, MA
4Depatment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
5Department of Cell Biology, Emory University School of Medicine, Atlanta, GA
6Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Newton, MA
7Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
8Department of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA
9Department of Nephrology, University of Texas Southwestern Medical Center, Dallas, TX

10:45 AM

Alexander Dupuy1,2*, Xiaoming Liu1,3*, Jessica Tieng, BSc (Hons)1,3,4*, Bede Johnston1,3*, Arian Nasser1,3*, Paul Coleman3,4*, Yingqi Zhang5*, Lining Arnold Ju5*, Huyen Tran, MD, PhD6,7*, Vivien M Chen, MBBS, PhD8,9, Elizabeth E. Gardiner, PhD10 and Freda H. Passam, MD, PhD3,11,12

1Heart Research Institute, Sydney, NSW, Australia
2Central Clinical School, University of Sydney, Camperdown, Australia
3Central Clinical School, University of Sydney, Sydney, NSW, Australia
4Centenary Institute, Sydney, NSW, Australia
5School of Biomedical Engineering, University of Sydney, Sydney, NSW, Australia
6Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia
7Alfred Hospital, Melbourne, Australia
8Department of Haematology, Concord Repatriation General Hospital, Sydney, NSW, Australia
9ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia
10ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia
11Haematology Research Group, Heart Research Institute, Sydney, NSW, Australia
12Haematology, Royal Prince Alfred Hospital, Sydney, NSW, Australia

11:00 AM

Abbey Willcox, FRACP, FRCPA, MBBS1*, Xiaowei Wang, PhD2*, Carly Selan, BSc3*, Natsha Lee, BSc (Hons)4*, Ilaria Calvello4*, Viktoria Bongcaron5*, Aidan Walsh5*, Yuyang Song6*, Simon C. Robson, MD, PhD7*, Karlheinz Peter, MD, PhD8*, Maithili Sashindranath, PhD3* and Harshal Nandurkar, MD, PhD9

1Alfred Health and Monash University, Melbourne, VIC, Australia
2Baker Institute, Melbourne, Australia
3Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
4Monash University, Melbourne, VIC, Australia
5Baker Heart and Diabetes Institute, Melbourne, AUS
6Baker Heart and Diabetes Institute, Melbourne, Australia
7Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
8Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia
9Australian Centre of Blood Diseases, Monash University and Alfred Health, Melbourne, Australia

11:15 AM

Dominic W. Chung, PhD1, Kimsey Platten, BS2*, Koya Ozawa, MD, PhD3*, Raymond Adili, MD1, Nathalie Pamir, PhD4*, Forrest D Nussdorfer, MS1*, Alexander E St. John, MD5*, Minhua Ling, PhD1*, Jennie Le, BS1*, Jeff Harris, BS1*, Junmei Chen, PhD1, Sergio Fazio, MD, PhD6*, Jonathan Lindner, MD7* and José A. López, MD1

1Bloodworks Research Institute, Seattle, WA
2Washington University, St Louis, MO
3Department of Medicine and Health, the University of Sydney, Kingswood, NSW, AUS
4Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR
5Department of Emergency Medicine, University of Washington, Seattle, WA
6Regeneron, Basking Ridge, NJ
7University of Virginia, Charlottesville, VA

11:30 AM

Abigail S McGovern, BSc(Hons)1*, Pia Larsson, PhD2*, Volga Tarlac2*, Juan Nunez-Iglesias, PhD1*, Stephen Cody3*, Lars Faxälv, PhD4*, Justin R Hamilton, PhD2 and Niklas Boknäs, MD, PhD5*

1Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia
2Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
3Monash Micro Imaging, Monash University, Melbourne, Australia
4Linköping University, Linköping, Sweden
5Department of Hematology and Department of Biomedical and Clinical Sciences, Linköping, Linköping, Sweden

11:45 AM

Lin Di1,2*, Asha Thomas, PhD3*, Kenneth A Kalikasingh3*, Stephanie D Lapping, MS2*, Andrei Maiseyeu1,2* and Lalitha Nayak, MD2,3

1Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH
2Cardiovascular Research Institute, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH
3Department of Medicine, Division of Hematology and Oncology, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH

*signifies non-member of ASH